All News

Camber recently announced the FDA approval of Tolterodine Tartrate ER capsules, a generic version of Detrol LA (tolterodine, Pharmacia & Upjohn).

Pharmacy DIR fees increasingly are being misused by payers to retroactively claw back reimbursement to pharmacies for the prescription drugs that they provide to Medicare beneficiaries.

The FDA announced approval of Wixela Inhub on January 30, 2019.

An FDA Advisory Committee has recommended the agency’s approval of Janssen’s esketamine nasal spray CIII (Spravato) for adults living with treatment-resistant depression.

The generic product (Wixela Inhub, Mylan) will be offered in 3 strengths at wholesale acquisition costs that are 70% less than the brand equivalent Advair Diskus, according to Mylan.

Biologic therapy used to treat severe psoriasis found to improve coronary artery plaque burden.

Daratumumab was first approved in November 2015 as the first and only CD38-directed antibody for the treatment of patients with multiple myeloma who have received at least 3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent, or who are double refractory to both.

The new approval allows for daratumumab (Darzalex) to be administered as a split infusion over 2 consecutive days.

ICI therapy offers a new way to treat cancer, yet clinical trials have often excluded those with HIV due to concerns that it may have negative effects, such as virus reactivation.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Flouxetine tablets were approved with the indication of treating multiple mental disorders.

Sephin1 found to protect oligodendrocytes, axons, and myelin, as well as reduce central nervous system inflammation in multiple sclerosis.

Although many pharmacists are divided when it comes to their job satisfaction, most of them are currently happy with their compensation, according to a recent Pharmacy Times® Salary and Job Satisfaction Survey.

The collaborating drug companies cut prices in an effort to make their drugs more accessible.

Warning letters and online advisory letters were posted to the agency's website for 58 products, mostly dietary supplements.

The economics of one and done gene therapies dictate a revenue model that requires outcomes-based risk.

The supplemental Biologics License Application was filed based on positive overall survival data from a phase 3 clinical trial for pembrolizumab in the treatment of recurrent or metastatic head and neck squamous cell carcinoma.

There are currently no FDA-approved therapies for the prevention or treatment of acute graft-versus-host disease.

Immunotherapy may become a viable option for patients with cancer infected with HIV.

Top news of the day across the health care landscape.

Top news of the day across the health care landscape.

Can you solve why this lady had a mysterious heart attack?

Analysis finds universal screening for hepatitis C virus infection would be cost effective and provide greater benefit than the currently recommended birth cohort screening.

Pulmatrix is set to launch a clinical investigation on the product in 2019.

Researchers predict that the changing nature of the epidemic, driven by the illegal use of opioids such as heroin and fentanyl, has reduced the potential impact of programs that target prescription opioids.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

The program aims to reduce the amount of illegal or suspect prescription drugs distributed throughout the United States.